Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2025-01-29 00:00:00 ET · period of report 2025-01-27 · accession 0000950170-25-010597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-29 | 2025-01-27 | IRWD | Martini Gregory S. | CFO | A - Grant | $0.00 | +111.1K | 195.9K | +131% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-27 | A | A | 111,111 | $0.00 | 195,862 | D | — | — |